Lung Cancer Clinical Trial
Official title:
A Randomized Controlled Trial To Determine If Thoracoscopic Resection Of Subcentimetre Lung Nodules After Localization Using Percutaneously Inserted Platinum Microcoils Under CT Guidance Reduces Rate Of Conversion To Open Thoracotomy From 50% To 10%
LAY ABSTRACT
1. Statement of the health problem or issue: Of the estimated 24,000 Canadians who will be
diagnosed with lung cancer in 2008, 21,000 will die of their disease. Based on this
cancer incidence and survival data, the most promising current strategy for improving
outcome is screening and early detection. It is suggested that if lesions are
discovered at an earlier stage of disease, they will have a higher likelihood of being
treatable and therefore, survival will be improved. CT detection of growing small lung
nodules, many of which are non-cancerous (benign), raises the possibility of lung
cancer and thus causes anxiety in patients and referring clinicians. Unfortunately,
confident separation of benign from malignant small lung nodules cannot be reliably
achieved using CT or PET criteria. Pathologic diagnosis using needle or excision biopsy
is usually required.
Excision biopsy removes the entire nodule at one setting and eliminates the sampling
error associated with needle biopsy, making it appealing to physicians and patients. To
reduce post-operative pain and breathing difficulties, excision biopsy is often
performed using minimally invasive surgery (video assisted thoracoscopic surgery,
VATS). Finding small pulmonary nodules is often difficult with the minimally invasive
camera (VATS) and a bigger incision (thoracotomy) is necessary in more than 60% of our
patients.
We recently developed a technique of using platinum micro-coils, which are inserted in
the lung nodule using CT guidance, to locate the nodule with fluoroscopy and then
excise it with VATS. We have completed a pilot study (n=75 nodules; 69 patients) to
determine the effectiveness of this technique. Seventy three (97%) 4-24-mm nodules were
successfully removed at fluoroscopically guided VATS excision.
2. Objective of your project: To improve our ability to successfully excise small growing
lung nodules with minimally invasive VATS surgery using CT guided micro-coil
localization techniques.
3. How will you undertake your work? We propose to conduct a randomized controlled trial
to determine if the use of CT guided platinum microcoil markers for VATS excision of
subcentimetre pulmonary nodules can reduce the rate of conversion to open thoracotomy
from 50% to 10%.
4. What is unique/innovative about your project? New image guided minimally invasive
surgical technique for removing early growing cancers was developed at the Vancouver
General Hospital and the University of British Columbia. This has been published in
peer-reviewed journals and can potentially allow us to accurately locate and excise
suspicious lung nodules
5. Relevance to Lung Association's mission statement? Lung cancer remains a major health
problem in Canada. Early detection and screening programs allow for discovery of
nodules when they are still very small and therefore, likely curable. Excision biopsy
removes the entire nodule at one setting and eliminates the sampling error associated
with needle biopsy, making it appealing to patients and physicians. To reduce post
operative morbidity, costs and volume of lung removed, excision biopsy is often
performed using video assisted thoracoscopic surgery (VATS) techniques. Using a pilot
project grant from the BC Lung Association we have developed a new technique that
allows preoperative CT marking of the nodule and minimally invasive removal of the
lesion. We hope that this technique will allow earlier treatment of lung cancers and
improve survival in this devastating disease.
Intervention Description:
The pre-operative CT scan will be reviewed by the surgeon with the radiologist to determine
if the nodule can be excised using thoracoscopic staple wedge techniques. After informed
consent, the patient will be seen by an anesthesiologist to determine risks and benefits of
a general anesthetic. The patient will initially come to the CT scanner suite in the
radiology department. The CT guided percutaneous microcoil nodule localization procedure,
will be performed consciously under local anaesthesia Using sterile technique and local
anesthetic, a biopsy needle (22 gauge) pre-loaded with an 6 cm long platinum microcoil will
be placed 10mm deep to the suspicious pulmonary nodule using CT guidance. The coil will be
deployed such that one end will be adjacent to the nodule and the other end will lie free on
the: lung surface. The patient will be transferred to the Laurel OR where they will be
placed under general anesthesia with a double lumen endotracheal tube in order to allow
collapse of the involved lung during the thoracoscopic excision of the marked lung nodule.
The patient's blood pressures, oxygen levels, pulse and ECG will be monitored. The
thoracoscopic excision of the nodule will be performed using the microcoil as a localizing
device. Using the preoperative CT scan, the study surgeon will mark the insertion sites for
thoracoscopic instruments. Instruments for video-assisted thoracoscopy include a rigid 5 mm
thoracoscope, a light source, a video-camera and monitor, and 5 mm grasping forceps. The
patient will be draped. A 5mm thoracoscopic port is inserted into the thorax percutaneously
and the lung is examined with the thoracoscope. The nodule location will be identified by
the end of the microcoil that sits on the surface of the lung. A second 5 mm port is put in
place and the end of the microcoil grasped under thoracoscopic visualization. Multiple
endoscopic are placed via a third 12mm port and the nodule and coil are completely excised
under fluoroscopic guidance. The resected nodule is placed in an endoscopic bag and brought
out through the large port site. If the lesion cannot be excised by the VATS technique the
patient will undergo an open rib spreading thoracotomy for excision of the marked nodule.
The indications for thoracotomy at this time are:poor visualization of the lung, pleural
symphysis with scarring, uncontrollable bleeding or inability to completely resect the
lesion with the thoracoscopic endostapler.
The specimen is sent for frozen section pathological examination. If the lesion is benign
the thoracic cavity is irrigated with saline and a small chest tube is put in place and
attached to under water drainage. The incisions are then closed and the lung is re-expanded.
The patient is then transported to the post-anesthetic room similar to other patients
undergoing general anesthesia. If the lesion is a non-small cell cancer of the lung the
patient may undergo a sampling of lymph nodes at that time followed by formal lobectomy. If
the patient has inadequate pulmonary function to tolerate a lobectomy and the lesion has
been completely excised the surgeon may choose to stop the operation at that time and follow
the patient.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
| Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
| Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
| Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
| Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
| Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
| Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
| Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
| Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
| Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
| Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
| Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
| Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
| Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
| Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|